Cor Vasa 2019, 61(5):497-501 | DOI: 10.33678/cor.2019.043
Risk of annuloplasty and patch use in infective endocarditis mitral valve repair
- a Department of Heart Surgery, Medical Faculty, Pavol Jozef Šafárik University and the Eastern Slovak Institute for Cardiovascular Diseases Ltd., Košice, Slovakia
- b Department of Heart Surgery, Eastern Slovak Institute for Cardiovascular Diseases Ltd., Košice, Slovakia
The incidence of infective endocarditis is 3-10 per 100,000 people per year. Risk factors for this disease include heart-valve disease, the implantation of a prosthetic valve or intra-cardiac devices, drug use and patient immunodeficiency. A 38-year-old drug-using man with a history of mitral valve surgery with patch reconstruction and annuloplasty ring implantation due to infective endocarditis was admitted to the hospital because of recurrence of mitral valve endocarditis. Surgery confirmed the unaffected patch in the posterior leaflet and the ring affected by an abscess cavity. Explantation of the annuloplasty ring and implantation of a mechanical valve prothesis was performed. Advances in techniques of mitral valve repair, including NeoChords and patch use, make this procedure fea- sible for more and more patients with mitral valve infective endocarditis. The use of a patch appears to be a safe benefit for the patient. There is no clear opinion on the unconditional use of annuloplasty ring during mitral valve repair in the area of infective endocarditis. Moreover, the presented case in correlation with literature presents annuloplasty ring as a risk factor for infective endocarditis relapse.
Keywords: Annuloplasty ring, Infective endocarditis, Mitral valve repair, Mitral valve replacement, Patch use
Accepted: February 17, 2019; Published: October 20, 2019 Show citation
References
- Tao E, Wan L, Wang W, et al., The prognosis of infective endocarditis treated with biological valves versus mechanical valves: A meta-analysis, PLoS One 2017;12:e0174519.
Go to original source...
Go to PubMed...
- Toporcer T, Kolesár A, Ledecký M, et al. Late infective endocarditis of an Amplatzer atrial septal device twelve years after implantation. Cor Vasa 2018;60:e174-e178.
Go to original source...
- Athan E, Chu VH, Tattevin P, et al., Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 2012;307:1727-1735.
Go to original source...
Go to PubMed...
- Rajamannan NM. The risk of infective endocarditis in the 21st century. Indian Heart J 2013;65:452-453.
Go to original source...
Go to PubMed...
- Slipczuk L, Codolosa JN, Davila CD, et al. Infective endocarditis epidemiology over five decades: a systematic review, PLoS One 2013;8:e82665.
Go to original source...
Go to PubMed...
- Rostagno C, Carone E, Stefano PL. Role of mitral valve repair in active infective endocarditis: long term results. J Cardiothorac Surg 2017;12:29.
Go to original source...
Go to PubMed...
- Toyoda N, Itagaki S, Egorova NN, et al. Real-world outcomes of surgery for native mitral valve endocarditis. J Thorac Cardiovasc Surg 2017;154:1906-1912.e9.
Go to original source...
Go to PubMed...
- Perrotta S, Frojd V, Lepore V, et al. Surgical treatment for isolated mitral valve endocarditis: a 16-year single-centre experience. Eur J Cardiothorac Surg 2018;53:576-581.
Go to original source...
Go to PubMed...
- Solari S, De Kerchove L, Tamer S, et al. Active infective mitral valve endocarditis: is a repair-oriented surgery safe and durable? Eur J Cardiothorac Surg 2019;55:256-262.
Go to original source...
Go to PubMed...
- Nakamura K, Hashimoto K, Sakamoto Y, et al. Safe Use of Glutaraldehyde to Repair the Destroyed Valve in Active Infective Mitral Valve Endocarditis, Circ J 2018;82:2530-2534.
Go to original source...
Go to PubMed...
- Bedeir K, Reardon M, Ramlawi B. Infective endocarditis: perioperative management and surgical principles. J Thorac Cardiovasc Surg 2014;147:1133-1141.
Go to original source...
Go to PubMed...
- Harky A, Hof A, Garner M, et al. Mitral valve repair or replacement in native valve endocarditis? Systematic review and meta-analysis. J Card Surg 2018;33:364-371.
Go to original source...
Go to PubMed...
- Gardner MA, Hossack KF, Smith IR. Long-Term Results Following Repair for Degenerative Mitral Regurgitation - Analysis of Factors Influencing Durability. Heart Lung Circ 2018 Oct 17. pii: S1443-9506(18)31952-8. doi: 10.1016/j.hlc.2018.10.011. [Epub ahead of print]
Go to original source...
Go to PubMed...
- Mihaljevic T, Paul S, Leacche M, et al. Tailored surgical therapy for acute native mitral valve endocarditis. J Heart Valve Dis 2004;13:210-216.
Go to PubMed...
- Lee HA, Cheng YT, Wu VC, et al. Nationwide cohort study of mitral valve repair versus replacement for infective endocarditis. J Thorac Cardiovasc Surg 2018;156:1473-1483.e2.
Go to original source...
Go to PubMed...
- Antunes MJ. Mitral valve repair versus replacement for infective endocarditis. What is better in the "real world"? J Thorac Cardiovasc Surg 2018;156:1471-1472.
Go to original source...
Go to PubMed...
- Lazar HL. Mitral valve repair for patients with infectious endocarditis. Is it the procedure of choice for all patients? J Card Surg 2018;33:372-373.
Go to original source...
Go to PubMed...
- Linhartová K, Beneš J, Gregor P. 2015 ESC Guidelines for the management of infective endocarditis. Summary document prepared by the Czech Society of Cardiology. Cor Vasa 2016;58:e107-e128.
Go to original source...
- Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:e57-e185.
Go to original source...
Go to PubMed...
- Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-3128.
Go to original source...
Go to PubMed...
- Delahaye F, Chu VH, Altclas J, et al. One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol 2015;178:117-123.
Go to original source...
Go to PubMed...
- Savage EB, Saha-Chaudhuri P, Asher CR, et al. Outcomes and prosthesis choice for active aortic valve infective endocarditis: analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2014;98:806-814.
Go to original source...
Go to PubMed...
- Nguyen DT, Delahaye F, Obadia JF, et al. Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses. Eur J Cardiothorac Surg 2010;37:1025-1032.
Go to original source...
Go to PubMed...
- Fedoruk LM, Jamieson WR, Ling H, et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg 2009;137:326-333.
Go to original source...
Go to PubMed...
- Kim JB, Ejiofor JI, Yammine M, et al. Are homografts superior to conventional prosthetic valves in the setting of infective endocarditis involving the aortic valve? J Thorac Cardiovasc Surg 2016;151:1239-1246, 1248.e1-2.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.